Condition: Healthy Volunteers (HV) · Sponsor: Jade Biosciences, Inc.
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.
This description comes directly from the study's public registry record.
Han · +1-888-228-7425 · study.losangeles@parexel.com
Always discuss trial participation with your own doctor first.
| Parexel Early Phase Clinical Unit (EPCU) | Glendale, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07525947